Company Description
Aeolus Pharmaceuticals, Inc. Formerly known as Incara Pharmaceuticals, Inc.. The Group's principal activities are to develop a series of catalytic antioxidant molecules which protect against the damaging effects of reactive oxygen derived molecules. ...
Related Business Topics
Breaking News
Reuters - November 05, 2009 7:10 AM
MISSION VIEJO, Calif.--(Business Wire)-- Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today the presentation of data at the GHSI Public Health Emergency Medical Countermeasures Workshop detailing the potential of AEOL 10150 as a broad spectrum ...
Reuters - November 04, 2009 11:56 AM
Data Supports Compound's Potential as a Countermeasure for Chlorine Gas Exposure MISSION VIEJO, Calif.--(Business Wire)-- Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) reported that researchers from National Jewish Health and McGill University have ...
Forbes.com - November 04, 2009 11:01 AM
Forbes.com - October 22, 2009 10:37 AM
BusinessWire - --Drug Improves Survival When Administered 24 Hours after Total Body Irradiation Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that recent experiments in preclinical models conducted by the National Institutes of Health's ...
Reuters - October 15, 2009 10:09 AM
AEOL 10150: - significantly increased mice survival from radiation - protected lung tissue from radiation-induced inflammation by removing Reactive Oxygen & Reactive Nitrogen Species (Free Radicals) and regulating HIF-1a signaling - protected mice ...
Pharmaceutical Companies
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.biopharminsight.com
Daily Drug Pipeline Updates Pharmaceutical Company Profiles
www.biopharminsight.com
